Jennison Associates Portfolio holdings
Jennison Associates, founded in 1969 and headquartered in New York City, is a global investment management firm managing over $194 billion in assets as of late 2024, specializing in active equity and fixed-income strategies. A subsidiary of PGIM, the asset management arm of Prudential Financial, Jennison serves a diverse client base—including institutions, sub-advisory clients, public plans, endowments, and corporations—with a focus on fundamental research, bottom-up portfolio construction, and high-conviction investing. Known for its equity expertise across styles, geographies, and market capitalizations, as well as investment-grade fixed-income offerings, the firm employs seasoned portfolio managers averaging 29 years of industry experience and 16 years with Jennison. With additional offices in Boston and a culture emphasizing intellectual rigor and long-term client outcomes, Jennison has built a reputation for excellence and stability in the investment management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vertex Pharmaceuticals
VRTX
|
+$858M |
| 2 |
Costco
COST
|
+$557M |
| 3 |
UnitedHealth
UNH
|
+$551M |
| 4 |
Atlassian
TEAM
|
+$489M |
| 5 |
Northrop Grumman
NOC
|
+$357M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Nike
NKE
|
+$579M |
| 2 |
TSMC
TSM
|
+$433M |
| 3 |
Airbnb
ABNB
|
+$426M |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$341M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$231M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 27.22% |
| 2 | Consumer Discretionary | 23.3% |
| 3 | Healthcare | 16.47% |
| 4 | Financials | 9.42% |
| 5 | Communication Services | 7.65% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ALEX
601
DELISTED
Alexander & Baldwin
ALEX
| – | – |
-48,635
| Closed | -$873K |
|
602
Alkermes
ALKS
$8.31B
| – | – |
-31,490
| Closed | -$938K |
|
603
AMN Healthcare
AMN
$1.28B
| – | – |
-5,970
| Closed | -$655K |
|
604
Associated Banc-Corp
ASB
$5.93B
| – | – |
-86,807
| Closed | -$1.58M |
|
605
AutoZone
AZO
$48.8B
| – | – |
-1,044
| Closed | -$2.24M |
|
|
BAND
606
Bandwidth Inc
BAND
$1.4B
| – | – |
-36,889
| Closed | -$694K |
|
607
Beam Therapeutics
BEAM
$2.67B
| – | – |
-14,359
| Closed | -$556K |
|
608
BHP
BHP
$212B
| – | – |
-132,614
| Closed | -$7.45M |
|
609
Bilibili
BILI
$8.05B
| – | – |
-356,896
| Closed | -$9.14M |
|
610
BP
BP
$109B
| – | – |
-31,268
| Closed | -$886K |
|
611
Crown Castle
CCI
$33.5B
| – | – |
-4,408
| Closed | -$742K |
|
612
Ciena
CIEN
$55.3B
| – | – |
-216,810
| Closed | -$9.91M |
|
613
Cencora
COR
$60B
| – | – |
-10,223
| Closed | -$1.45M |
|
614
Cognizant
CTSH
$24.9B
| – | – |
-9,823
| Closed | -$663K |
|
615
California Water Service
CWT
$3.05B
| – | – |
-16,455
| Closed | -$914K |
|
616
Dell
DELL
$302B
| – | – |
-35,111
| Closed | -$1.62M |
|
|
DOCU
617
DocuSign
DOCU
$10.5B
| – | – |
-9,327
| Closed | -$535K |
|
618
GrafTech
EAF
$195M
| – | – |
-8,971
| Closed | -$634K |
|
619
iShares MSCI EAFE ETF
EFA
$79.3B
| – | – |
-6,260
| Closed | -$391K |
|
620
Elevance Health
ELV
$83B
| – | – |
-4,420
| Closed | -$2.13M |
|
621
Entegris
ENTG
$22B
| – | – |
-280,163
| Closed | -$25.8M |
|
622
Evertec
EVTC
$1.92B
| – | – |
-31,401
| Closed | -$1.16M |
|
623
Edwards Lifesciences
EW
$51.6B
| – | – |
-7,968
| Closed | -$758K |
|
|
FOLD
624
DELISTED
Amicus Therapeutics
FOLD
| – | – |
-65,788
| Closed | -$707K |
|
625
First Industrial Realty Trust
FR
$8.69B
| – | – |
-113,018
| Closed | -$5.37M |
|
Similar funds
Jennison Associates's Q3 2022 Portfolio in Review
As of Q3 2022, Jennison Associates held 689 positions worth $101B, up 0.37% from $100B the previous quarter. Its ten largest holdings account for 40% of the portfolio.
Jennison Associates's Q3 2022 filing shows 75 new, 294 increased, 218 reduced and 90 closed positions. Its largest new stake was T-Mobile US: 1,657,443 shares worth $222M. The largest sale was Nike, an estimated $579M.
By sector, the portfolio is most concentrated in Technology at 27% of assets, down from 28% a quarter earlier, followed by Consumer Discretionary and Healthcare.
- Jennison Associates's largest Q3 2022 buy was T-Mobile US: 1,657,443 shares worth $222M.
- Jennison Associates added most to Vertex Pharmaceuticals in Q3 2022, an estimated $858M increase.
- Jennison Associates's biggest Q3 2022 reduction was Nike, cutting an estimated $579M.
- Jennison Associates fully exited Snap in Q3 2022, selling an estimated $197M.
- Jennison Associates's ten largest holdings make up 40% of its $101B portfolio in Q3 2022.
- Jennison Associates opened 75 new positions and closed 90 in Q3 2022.
- Jennison Associates's portfolio value rose 0.37% quarter-over-quarter to $101B.
Based on Jennison Associates's 13F filing for Q3 2022, filed 1 Nov 2022.